文献速递产科母胎医学

穿透性胎盘植入与严重母体并发症的发生频率高于植入性胎盘

Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta.
PubMed 文献 · Am J Obstet Gynecol · 2018-05-05

该回顾性研究纳入2003年至2017年巴黎一家转诊中心全部异常侵入性胎盘植入孕妇,比较穿透性胎盘植入与植入性胎盘/粘连性胎盘的母体结局。穿透性胎盘植入组的严重急性母体并发症复合指标显著高于植入性胎盘组(86.3% vs 26.7%,P < .001),子宫切除率也更高。

要点

  • 穿透性胎盘植入组严重母体并发症复合指标发生率为86.3%(44/51),植入性胎盘组为26.7%(28/105),差异显著(P < .001)。
  • 穿透性胎盘植入组产前疑诊率(96.1%)远高于植入性胎盘组(25.7%),产前决定保守处理的比例也更高(100% vs 40.7%)。
  • 穿透性胎盘植入组剖宫产时子宫切除率为52.9%(27/51),植入性胎盘组为20.9%(22/105),总子宫切除率分别为84.3%和23.8%。

核心结论

  • 尽管有多学科规划、转诊中心管理和更好的产前疑诊,穿透性胎盘植入孕妇的严重母体并发症仍比植入性胎盘孕妇常见得多。

研究设计与样本

  • 本研究为巴黎一家转诊中心的回顾性研究,纳入2003年至2017年所有异常侵入性胎盘植入孕妇,共156例,其中穿透性胎盘植入51例,植入性胎盘105例。
  • 穿透性胎盘植入和植入性胎盘通过组织学或临床诊断。
  • 产前怀疑穿透性胎盘植入时,因剖宫产术中风险而提出保守处理(胎盘原位保留);怀疑植入性胎盘时,向父母提供保守处理或尝试剥离胎盘(失败后行子宫切除)的选择。
  • 主要结局指标为严重急性母体并发症复合标准,包括以下至少一项:剖宫产时子宫切除、延迟子宫切除、输注≥10单位浓缩红细胞、感染性休克、急性肾损伤、心血管衰竭、母体转入重症监护或死亡。

主要发现

  • 穿透性胎盘植入组产前疑诊异常侵入性胎盘植入的比例为96.1%(49/51),植入性胎盘组为25.7%(27/105),差异有统计学意义(P < .01)。
  • 在76例产前疑诊异常侵入性胎盘植入的孕妇(48.7%)中,穿透性胎盘植入组产前决定保守处理的比例为100%(49/49),植入性胎盘组为40.7%(11/27),差异有统计学意义(P < .01)。
  • 穿透性胎盘植入组严重母体并发症复合指标发生率为86.3%(44/51),植入性胎盘组为26.7%(28/105),差异有统计学意义(P < .001)。
  • 在异常侵入性胎盘植入直径>6 cm的孕妇中,二次分析显示穿透性胎盘植入组复合指标发生率为86.0%(43/50),植入性胎盘组为48.7%(19/38),差异有统计学意义(P < .01)。
  • 穿透性胎盘植入组剖宫产时子宫切除率为52.9%(27/51),植入性胎盘组为20.9%(22/105),差异有统计学意义(P < .01);总子宫切除率分别为84.3%(43/51)和23.8%(25/105),差异有统计学意义(P < .01)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Abnormally invasive placentation is the leading cause of obstetric hysterectomy and can cause poor to disastrous maternal outcomes. Most previous studies of peripartum management and maternal morbidity have included variable proportions of severe and less severe cases. OBJECTIVE: The aim of this study was to compare maternal morbidity from placenta percreta and accreta. STUDY DESIGN: This retrospective study at a referral center in Paris includes all women with abnormally invasive placentation from 2003 through 2017. Placenta percreta and accreta were diagnosed histologically or clinically. When placenta percreta was suspected before birth, a conservative approach leaving the placenta in situ was proposed because of the intraoperative risk of cesarean delivery. When placenta accreta was suspected, parents were offered a choice of a conservative approach or an attempt to remove the placenta, to be followed in case of failure by hysterectomy. Maternal outcomes were compared between women with placenta percreta and those with placenta accreta/increta. The primary outcome measure was a composite criterion of severe acute maternal morbidity including at least 1 of the following: hysterectomy during cesarean delivery, delayed hysterectomy, transfusion of ≥10 U of packed red blood cells, septic shock, acute kidney injury, cardiovascular failure, maternal transfer to intensive care, or death. RESULTS: Of the 156 women included, 51 had placenta percreta and 105 placenta accreta. Abnormally invasive placentation was suspected antenatally nearly 4 times more frequently in the percreta than the accreta group (96.1% [49/51] vs 25.7% [27/105], P < .01). Among the 76 women with antenatally suspected abnormally invasive placentation (48.7%), the rate of antenatal decisions for conservative management was higher in the percreta than the accreta group (100% [49/49] vs 40.7% [11/27], P < .01). The composite maternal morbidity rate was significantly higher in the percreta than the accreta group (86.3% [44/51] vs 28/105 [26.7%], P < .001). A secondary analysis restricted to women with an abnormally invasive placentation diameter >6 cm showed similar results (86.0% [43/50) vs 48.7% [19/38), P < .01). The rate of hysterectomy during cesareans was significantly higher in the percreta than the accreta group (52.9% [27/51] vs 20.9% [22/105], P < .01) as was the total hysterectomy rate (43/51 [84.3%] vs 23.8% [25/105], P < .01). CONCLUSION: Severe maternal morbidity is much more frequent in women with placenta percreta than with placenta accreta, despite multidisciplinary planning, management in a referral center, and better antenatal suspicion.

来源:Am J Obstet Gynecol,查看原文。版权归原作者所有。

引用

  1. Marcellin L, Delorme P, Bonnet MP, et al. Placenta percreta is associated with more frequent severe maternal morbidity than placenta accreta. Am J Obstet Gynecol. 2018. PMID: 29733839. doi:10.1016/j.ajog.2018.04.049

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。